Clinique du Sommei, Service d'Explorations Fonctionnelles du Système Nerveux, CHU de Bordeaux, Place Amélie Raba-Léon, 33076, Bordeaux, France.
USR CNRS 3413 SANPSY, Université de Bordeaux, 33076, Bordeaux, France.
Sleep Breath. 2019 Mar;23(1):217-226. doi: 10.1007/s11325-018-1686-7. Epub 2018 Jun 26.
The Self-Efficacy Measure for Sleep Apnea (SEMSA) is a 26-item self-questionnaire composed of three factors: risk perception of obstructive sleep apnea syndrome (OSAS), benefit of continuous positive airway pressure (CPAP), and self-efficacy (the confidence to engage in CPAP use). It is used to evaluate health beliefs about OSAS and CPAP in order to optimize CPAP use. The purpose of this study was to design and validate a French version of the SEMSA.
A forward-backward translation of the SEMSA was performed. Subjects with OSAS treated by CPAP and followed by our sleep clinic were invited to complete the questionnaire. The psychometric properties of the French SEMSA version were analyzed in terms of its construct validity (with confirmatory factor analysis, CFA), internal structural validity (Cronbach's alpha coefficient), and external validity (Pearson's correlation between SEMSA score and duration of CPAP use).
Two hundred eighty-eight subjects filled in the questionnaire. The mean age was 63.16 ± 12.73 years. The number of years since the beginning of CPAP treatment was 6.58 ± 6.03 years. The mean CPAP use duration was 6.19 ± 2.03 h/night. CFA was unsatisfactory (RMSEA = 0.066 and CFI = 0.88). The exploratory factor analysis revealed a fourth factor named "cardiovascular risk" factor. Cronbach's alpha coefficient was 0.886. The correlation between the "self-efficacy" factor and the duration of CPAP use was significant (r = 0.26, p ≤ 0.001).
The French version of the SEMSA is a psychometrically acceptable self-report questionnaire for measuring health beliefs and behavior in French patients with OSAS treated with CPAP. Such translation and validation should lead to the adoption of validated psychosocial methods for improving CPAP use.
睡眠呼吸暂停自我效能量表（SEMSA）是一个由 26 个项目组成的自我问卷，包含三个因素：阻塞性睡眠呼吸暂停综合征（OSAS）风险感知、持续气道正压通气（CPAP）获益和自我效能（使用 CPAP 的信心）。它用于评估对 OSAS 和 CPAP 的健康信念，以优化 CPAP 的使用。本研究的目的是设计和验证 SEMSA 的法语文本。
通过向前和向后翻译 SEMSA 来完成。邀请接受 CPAP 治疗并在我们的睡眠诊所接受随访的 OSAS 患者完成问卷。用法语版 SEMSA 版本的心理测量特性进行分析，包括其构建有效性（通过验证性因子分析，CFA）、内部结构有效性（Cronbach's alpha 系数）和外部有效性（SEMSA 评分与 CPAP 使用时间之间的 Pearson 相关关系）。
288 名受试者填写了问卷。平均年龄为 63.16±12.73 岁。CPAP 治疗开始以来的年数为 6.58±6.03 年。平均 CPAP 使用时间为 6.19±2.03 小时/夜。CFA 结果不理想（RMSEA=0.066，CFI=0.88）。探索性因子分析显示出第四个因子，命名为“心血管风险”因子。Cronbach's alpha 系数为 0.886。“自我效能”因子与 CPAP 使用时间之间的相关性具有统计学意义（r=0.26，p≤0.001）。
法语版 SEMSA 是一种心理测量学上可接受的自我报告问卷，用于测量接受 CPAP 治疗的法语文本 OSAS 患者的健康信念和行为。这种翻译和验证应该导致采用经过验证的社会心理方法来提高 CPAP 的使用。
